Cargando…
Correction to “Immunomodulation of the NLRP3 Inflammasome through Structure-Based Activator Design and Functional Regulation via Lysosomal Rupture”
Autores principales: | Manna, Saikat, Howitz, William J., Oldenhuis, Nathan J., Eldredge, Alexander C., Shen, Jingjing, Nihesh, Fnu Naorem, Lodoen, Melissa B., Guan, Zhibin, Esser-Kahn, Aaron P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276281/ https://www.ncbi.nlm.nih.gov/pubmed/30555913 http://dx.doi.org/10.1021/acscentsci.8b00752 |
Ejemplares similares
-
Immunomodulation of the NLRP3 Inflammasome through
Structure-Based Activator Design and Functional Regulation via Lysosomal
Rupture
por: Manna, Saikat, et al.
Publicado: (2018) -
A synthetic pathogen mimetic molecule induces a highly amplified synergistic immune response via activation of multiple signaling pathways
por: Nihesh, Naorem, et al.
Publicado: (2021) -
Improving the Adjuvanticity of Small Molecule Immune
Potentiators Using Covalently Linked NF-κB Modulators
por: Kimani, Flora W., et al.
Publicado: (2021) -
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
por: Silvis, Max J. M., et al.
Publicado: (2020) -
Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage
por: Hou, Yingting, et al.
Publicado: (2023)